Suppr超能文献

优化用于特异性激活靶信号分子的最小化工程受体。

Refining minimal engineered receptors for specific activation of on-target signaling molecules.

作者信息

Miura Masashi, Kawahara Masahiro

机构信息

Laboratory of Cell Vaccine, Microbial Research Center for Health and Medicine (MRCHM), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki-Shi, Osaka, 567-0085, Japan.

出版信息

Sci Rep. 2024 Dec 30;14(1):31671. doi: 10.1038/s41598-024-81259-4.

Abstract

Since designer cells are attracting much attention as a new modality in gene and cell therapy, it would be advantageous to develop synthetic receptors that recognize artificial ligands and activate solely signaling molecules of interest. In this study, we refined the construction of our previously developed minimal engineered receptors (MERs) to avoid off-target activation of STAT5 while maintaining on-target activation of signaling molecules corresponding to tyrosine motifs. Among the myristoylated, cytoplasmic, and transmembrane types of MERs, the cytoplasmic type had the highest signaling efficiency, although there was off-target activation of STAT5 upon ligand stimulation. Tyrosine-to-phenylalanine ​​mutagenesis revealed that both the tyrosine motif for recruiting target signaling molecules and the tyrosine residues in the JAK-binding domain did not contribute to off-target activation of STAT5. Using alanine mutagenesis for Box1 of the JAK-binding domain of MERs, we ultimately found a Box1 mutation that slightly reduced activation of on-target signaling molecules but minimized off-target activation of STAT5. The refined MER enabled us to precisely analyze the signaling and cell fate-inducing properties of seven tyrosine motifs. Therefore, the refined MER, which realizes activation of on-target signaling molecules with high signal-to-noise ratios, will attract much attention as a tool for functionalizing designer cells and more broadly in the field of synthetic biology.

摘要

由于设计细胞作为基因和细胞治疗的一种新形式正备受关注,开发能够识别人工配体并仅激活感兴趣的信号分子的合成受体将具有优势。在本研究中,我们优化了之前开发的最小工程受体(MERs)的构建,以避免STAT5的脱靶激活,同时保持对应酪氨酸基序的信号分子的靶向激活。在肉豆蔻酰化、细胞质和跨膜类型的MERs中,细胞质类型具有最高的信号传导效率,尽管在配体刺激时存在STAT5的脱靶激活。酪氨酸到苯丙氨酸的诱变表明,招募靶信号分子的酪氨酸基序和JAK结合域中的酪氨酸残基均对STAT5的脱靶激活无贡献。通过对MERs的JAK结合域的Box1进行丙氨酸诱变,我们最终发现了一种Box1突变,该突变略微降低了靶向信号分子的激活,但使STAT5的脱靶激活最小化。优化后的MER使我们能够精确分析七种酪氨酸基序的信号传导和细胞命运诱导特性。因此,优化后的MER能够以高信噪比实现靶向信号分子的激活,作为一种使设计细胞功能化的工具以及在合成生物学领域更广泛地应用,将备受关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b1/11685922/d6bf98594aa4/41598_2024_81259_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验